Chan M P Y, Hungerford J L, Kingston J E, Plowman P N
Ocular Oncology Service, St Bartholomew's and The Royal London Hospitals, London, UK.
Br J Ophthalmol. 2009 Jul;93(7):891-4. doi: 10.1136/bjo.2007.129981. Epub 2009 Mar 26.
Radiation is implicated in the induction of second malignancies in children with bilateral retinoblastoma. There is a need to determine whether this risk can be justified by good visual outcome when external beam radiotherapy (EBRT) is used as a salvage treatment.
To study the effectiveness of EBRT as a salvage treatment after failed primary chemotherapy and focal treatment in bilateral retinoblastoma.
This is a retrospective observational case series. The outcome measures after EBRT are: rate of eye preservation, rate of tumour control, visual potential, visual acuity and radiation-induced side-effects.
Thirty-six eyes (22 patients) were included. The median follow-up after EBRT was 40 months (19-165 months). Thirty-two eyes received lens-sparing radiotherapy, and four received whole-eye radiation. The rate of eye preservation was 83.3% (30/36 eyes). Twenty-four eyes (66.7%) were controlled by EBRT and required no further treatment. Of the 30 preserved eyes, 20 eyes (66.7%) had extramacular tumours without retinal detachment and therefore potential for central vision. The final visual acuity was recorded for 19 eyes. Ten eyes (52.6%) read 6/9-6/5, three eyes (15.8%) read 6/18-6/36, and six eyes (31.6%) read 6/60 or worse. Significant radiation- induced side effects were limited to cataracts and dry eyes with whole-eye radiation. There were no second cancers or deaths.
Salvage EBRT is highly effective in preserving eyes with useful vision in bilateral retinoblastoma after failed chemotherapy and focal treatments. These results will help the parents and ophthalmologists of such patients to reach an informed decision when weighing up the benefits of EBRT against its potential oncogenic effect.
辐射与双侧视网膜母细胞瘤患儿继发第二恶性肿瘤有关。当使用外照射放疗(EBRT)作为挽救性治疗时,有必要确定这种风险是否能因良好的视力预后而被证明是合理的。
研究EBRT作为双侧视网膜母细胞瘤初始化疗和局部治疗失败后的挽救性治疗的有效性。
这是一项回顾性观察病例系列研究。EBRT后的结局指标包括:眼球保留率、肿瘤控制率、视力潜能、视力及放疗引起的副作用。
纳入36只眼(22例患者)。EBRT后的中位随访时间为40个月(19 - 165个月)。32只眼接受了晶状体保留放疗,4只眼接受了全眼球放疗。眼球保留率为83.3%(30/36只眼)。24只眼(66.7%)通过EBRT得到控制,无需进一步治疗。在30只保留的眼中,20只眼(66.7%)有黄斑外肿瘤且无视网膜脱离,因此有中心视力的潜能。记录了19只眼的最终视力。10只眼(52.6%)视力为6/9 - 6/5,3只眼(15.8%)视力为6/18 - 6/36,6只眼(31.6%)视力为6/60或更差。显著的放疗引起的副作用仅限于全眼球放疗后的白内障和干眼。无第二癌症或死亡病例。
挽救性EBRT在双侧视网膜母细胞瘤化疗和局部治疗失败后保留有有用视力的眼球方面非常有效。这些结果将有助于此类患者的家长和眼科医生在权衡EBRT的益处与其潜在致癌作用时做出明智的决定。